Looking to publish in CNS Neuroscience & Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowCNS Neuroscience & Therapeutics is an open access journal publishing research related to the central nervous system, clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.
Looking to publish in CNS Neuroscience & Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
CNS Neuroscience & Therapeutics accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Reviews
Meta-Analyses
Clinical Guidelines
Letters To The Editor
Letter To The Journal
Recent Publications
Lecanemab Reduces Neuropsychiatric Symptoms and Related Regional Brain Amyloid Load in Early Alzheimer's Disease: A Preliminary Prospective Study
Yan Chang, Hua Li, Xiaojie Liu, Xuemei Li, Jiajin Liu, Jingbin Song, Huaping Fu, Xiaodan Xu, Yuan Wang, Qianyao Wang, Na Ren, Jilin Chen, Xin Deng, Xue Zhang, Luofei Zuo, Bo Zhou, Xuan Sun, Zihan Li, Yuanyan Cao, Runze Wu, Jianjun Jia, Hairong Qian, Ruimin Wang
USP5 ‐C‐ MAF Axis Regulates Autophagy‐Dependent Neuronal Ferroptosis in Spinal Cord Injury Therapeutics
Shiyang Weng, Kai Wu, Yinjun Huang, Lei Cao, Huichao Fu
Neuroprotective Effects of Phenothiazines on Acute Ischemic Stroke
Qi Wang, Weili Li, Di Wu, Shuaili Xu, Xunming Ji
Restoration of Excitation‐Inhibition Balance and Improvement of Schizophrenia‐like Behavioral Deficits via Electroacupuncture
Chaofan Wan, Yucen Xia, Jinglan Yan, Weipeng Lin, Yuanjia Zheng, Yiqiu Lin, Lin Yao, Yongjun Chen
Synergistic Interaction Between MALAT1/miR‐30b‐5p/BAFF Axis and Inflammatory Cytokines Underlies Rituximab‐Refractory NMOSD
Meiqun Deng, Keyi Zeng, Wei Chen, Jing Chen, Xiaoting Lin, Lei Chen, Yuxin Yao, Hanfei Chen, Aiyu Lin
Frequently asked questions
How long does it take to publish?
Median submission to first decision is 21 days, median submission to acceptance is 133 days, and median acceptance to publication is 16 days.
Reformat to CNS Neuroscience & Therapeutics using Livewrite PremiumIs a cover letter required?
A cover letter should be included in the Cover Letter field of the submission system. It must acknowledge that all authors contributed significantly and state that all authors agree with the manuscript content and its submission to CNS Neuroscience & Therapeutics.
Reformat to CNS Neuroscience & Therapeutics using Livewrite PremiumWhat are the publication costs?
APC: $4,550 USD / £3,450 GBP / €3,900 EUR for accepted and published articles. Editorial Commentary and Clinical Guidelines are waived.
Reformat to CNS Neuroscience & Therapeutics using Livewrite Premium